Programme

Explore our interdisciplinary programme. Build your own schedule by adding sessions to your calendar.

Griffiths Hall

Feilding Forum

Susi Salon

09:00

09:30

10:00

10:30

11:00

11:30

12:00

12:30

13:00

13:30

14:00

14:30

15:00

15:30

16:00

16:30

17:00

17:30

18:00

18:30

19:00

19:30

Oral09:15–09:40

OPENing

Keynote

Oral09:50–10:20

The 51% blind spot: Psychedelics, women's health and the opportunity we must not miss

Grace Blest-Hopley

Psychedelics in psychiatry and psychotherapy

Oral10:30–10:55

Altered states and the future of psychopathology: Psychedelics in historical and philosophical perspective

Damiaan Denys

Oral10:55–11:20

Common factors of psychotherapy in psychedelic-assisted therapy (PAT)

Peter Gasser

Symposium11:50–12:50

From experience to outcome: Psychological change processes in psychedelic research

Helena Aicher
Susanne Prinz
Óscar Soto Angona
Max Wolff

Keynote

Oral14:20–15:00

From getting high to getting healthy: Recent research on psychoactive drugs

Harriet de Wit

Keynote

Oral15:10–15:50

From Mexico to Lesotho: Rethinking the scope and history of traditional psychedelic use

Manvir Singh

Symposium16:20–17:20

Rewiring addiction: Psychedelic therapy from brain circuits to lived recovery

Celia Morgan
Rayyan Zafar
Alison Chapman
David Erritzoe
Rebecca Harding

Panel17:30–18:15

Toward a western psychedelic practice lineage: standards, care, and the future of practitioner education

Daan Keiman
Duncan Still
Simon Ruffell
Léla Mosemghvlishvili

Keynote

Oral09:50–10:20

Psychedelic therapy as the reconstruction of meaning

Christopher Timmermann

Industry, Policy and Access Pathways

Oral10:30–10:55

The state of the psychedelic industry and policy

Josh Hardman

Oral10:55–11:20

Are reimbursement pathways ready for licensed psychedelic therapies in Europe?

Floris Wolswijk

Panel11:50–12:50

Political, spiritual and cultural perspectives on ayahuasca

Álvaro Tukano
Christian Tym
Brigitte Adriaensen
Tarire Mutzarawa

Psychedelics at the end of life

Oral14:20–14:40

Irremediable psychiatric suffering and euthanasia requests: A potential indication for psilocybin treatment

Metten Somers

Oral14:40–15:00

The right to die well: MAID, psychedelics, and humane end-of-life care

Houman Farzin

Participant perspectives

Oral15:10–15:50

From patients to partners: Early insights from a patient-led care model following psychedelic treatment (supported by the Norrsken Mind Participant Fellowship)

Leonie Schneider, Ian Roullier, Caroline Lilley

Panel16:20–17:20

Clinical trial experts by experience: A dose of reality (supported by the Norrsken Mind lived experience fellowship)

Amy Atkins
Leonie Schneider
Jo Giblin
Ian Roullier

Artistic17:30–18:15

Live HandPan Meditation with Reo Matsumoto

Psychedelic Humanities

Oral09:50–10:20

The psychedelic humanities: A posthuman proposal for the community of psychedelic professionals

Daan F Oostveen

Challenging Experiences

Oral10:30–10:55

Persisting psychological complications following the use of classic psychedelics: A qualitative study of help-seeking experiences

Lisa Maria Jöbstl

Oral10:55–11:20

When therapy falls short: A qualitative study of psychotherapy after challenging experiences and the need for psychedelic-informed therapy

Guy Simon

Symposium11:50–12:50

Remembering our original nature – ecological dimensions of psychedelics, health, and the self

Cecilie Byholt Endresen
Brian Stafford
Sam Gandy
Simon Ruffell

Psychedelics in religious contexts

Oral14:20–14:40

Crossing orthodox boundaries: The emergence of ayahuasca use in the ultra-orthodox (Haredi) world

Jonathan David

Oral14:40–15:00

“This is a medicine that brings you back to yourself. And therefore it brings you back to God”: Muslim women’s experiences with psychedelics

Manzar Zare

PAT: Qualitative research in underserved populations

Oral15:10–15:30

Ketamine-assisted group therapy to address identity-related trauma: Qualitative findings among transgender and gender expansive adults

Sabrina Cluesman

Oral15:30–15:50

Accelerated recovery using magnesium ibogaine: Characterizing the subjective experience of its rapid healing from neuropsychiatric disorders

Clayton Olash

Symposium16:20–17:20

Psychedelics and the intimate self: Sexuality, gender, and relationships

Dee Dee Goldpaugh
Pat Song
Daniel Kruger

Symposium17:30–18:15

Asian psychedelia: Family, governance, and postcolonial tensions in psychedelic treatments

Xiaofan Sun
Minsu Yoo
Jennifer Docherty

Panel18:15–19:15

Psychedelic therapy and the boundaries of professional responsibility: Reflections on a recent Dutch disciplinary case

Metten Somers
Tadeusz Hawrot
Tonnie Prinsen-Reinders

Room change09:40–09:50

Room change10:20–10:30

Break11:20–11:50

Lunch12:50–14:20

Room change15:00–15:10

Break15:50–16:20

Room change17:20–17:30

Griffiths Hall

09:00

09:30

10:00

10:30

11:00

11:30

12:00

12:30

13:00

13:30

14:00

14:30

15:00

15:30

16:00

16:30

17:00

17:30

18:00

18:30

19:00

19:30

Oral09:15–09:40

OPENing

Keynote

Oral09:50–10:20

The 51% blind spot: Psychedelics, women's health and the opportunity we must not miss

Grace Blest-Hopley

Psychedelics in psychiatry and psychotherapy

Oral10:30–10:55

Altered states and the future of psychopathology: Psychedelics in historical and philosophical perspective

Damiaan Denys

Oral10:55–11:20

Common factors of psychotherapy in psychedelic-assisted therapy (PAT)

Peter Gasser

Symposium11:50–12:50

From experience to outcome: Psychological change processes in psychedelic research

Helena Aicher
Susanne Prinz
Óscar Soto Angona
Max Wolff

Keynote

Oral14:20–15:00

From getting high to getting healthy: Recent research on psychoactive drugs

Harriet de Wit

Keynote

Oral15:10–15:50

From Mexico to Lesotho: Rethinking the scope and history of traditional psychedelic use

Manvir Singh

Symposium16:20–17:20

Rewiring addiction: Psychedelic therapy from brain circuits to lived recovery

Celia Morgan
Rayyan Zafar
Alison Chapman
David Erritzoe
Rebecca Harding

Panel17:30–18:15

Toward a western psychedelic practice lineage: standards, care, and the future of practitioner education

Daan Keiman
Duncan Still
Simon Ruffell
Léla Mosemghvlishvili

Room change09:40–09:50

Room change10:20–10:30

Break11:20–11:50

Lunch12:50–14:20

Room change15:00–15:10

Break15:50–16:20

Room change17:20–17:30

09:00

09:30

10:00

10:30

11:00

11:30

12:00

12:30

13:00

13:30

14:00

14:30

15:00

15:30

16:00

16:30

17:00

17:30

18:00

18:30

19:00

19:30

Keynote

Oral09:50–10:20

Psychedelic therapy as the reconstruction of meaning

Christopher Timmermann

Industry, Policy and Access Pathways

Oral10:30–10:55

The state of the psychedelic industry and policy

Josh Hardman

Oral10:55–11:20

Are reimbursement pathways ready for licensed psychedelic therapies in Europe?

Floris Wolswijk

Panel11:50–12:50

Political, spiritual and cultural perspectives on ayahuasca

Álvaro Tukano
Christian Tym
Brigitte Adriaensen
Tarire Mutzarawa

Psychedelics at the end of life

Oral14:20–14:40

Irremediable psychiatric suffering and euthanasia requests: A potential indication for psilocybin treatment

Metten Somers

Oral14:40–15:00

The right to die well: MAID, psychedelics, and humane end-of-life care

Houman Farzin

Participant perspectives

Oral15:10–15:50

From patients to partners: Early insights from a patient-led care model following psychedelic treatment (supported by the Norrsken Mind Participant Fellowship)

Leonie Schneider, Ian Roullier, Caroline Lilley

Panel16:20–17:20

Clinical trial experts by experience: A dose of reality (supported by the Norrsken Mind lived experience fellowship)

Amy Atkins
Leonie Schneider
Jo Giblin
Ian Roullier

Artistic17:30–18:15

Live HandPan Meditation with Reo Matsumoto

Room change09:40–09:50

Room change10:20–10:30

Break11:20–11:50

Lunch12:50–14:20

Room change15:00–15:10

Break15:50–16:20

Room change17:20–17:30

09:00

09:30

10:00

10:30

11:00

11:30

12:00

12:30

13:00

13:30

14:00

14:30

15:00

15:30

16:00

16:30

17:00

17:30

18:00

18:30

19:00

19:30

Psychedelic Humanities

Oral09:50–10:20

The psychedelic humanities: A posthuman proposal for the community of psychedelic professionals

Daan F Oostveen

Challenging Experiences

Oral10:30–10:55

Persisting psychological complications following the use of classic psychedelics: A qualitative study of help-seeking experiences

Lisa Maria Jöbstl

Oral10:55–11:20

When therapy falls short: A qualitative study of psychotherapy after challenging experiences and the need for psychedelic-informed therapy

Guy Simon

Symposium11:50–12:50

Remembering our original nature – ecological dimensions of psychedelics, health, and the self

Cecilie Byholt Endresen
Brian Stafford
Sam Gandy
Simon Ruffell

Psychedelics in religious contexts

Oral14:20–14:40

Crossing orthodox boundaries: The emergence of ayahuasca use in the ultra-orthodox (Haredi) world

Jonathan David

Oral14:40–15:00

“This is a medicine that brings you back to yourself. And therefore it brings you back to God”: Muslim women’s experiences with psychedelics

Manzar Zare

PAT: Qualitative research in underserved populations

Oral15:10–15:30

Ketamine-assisted group therapy to address identity-related trauma: Qualitative findings among transgender and gender expansive adults

Sabrina Cluesman

Oral15:30–15:50

Accelerated recovery using magnesium ibogaine: Characterizing the subjective experience of its rapid healing from neuropsychiatric disorders

Clayton Olash

Symposium16:20–17:20

Psychedelics and the intimate self: Sexuality, gender, and relationships

Dee Dee Goldpaugh
Pat Song
Daniel Kruger

Symposium17:30–18:15

Asian psychedelia: Family, governance, and postcolonial tensions in psychedelic treatments

Xiaofan Sun
Minsu Yoo
Jennifer Docherty

Panel18:15–19:15

Psychedelic therapy and the boundaries of professional responsibility: Reflections on a recent Dutch disciplinary case

Metten Somers
Tadeusz Hawrot
Tonnie Prinsen-Reinders

Room change09:40–09:50

Room change10:20–10:30

Break11:20–11:50

Lunch12:50–14:20

Room change15:00–15:10

Break15:50–16:20

Room change17:20–17:30